Outside Publication

Foreign Investment in US Biotech Gets Greater Government Scrutiny, Law360

July 11, 2019

Morgan Lewis partners Carl Valenstein and Stephen Paul Mahinka and associate Beverly J. Dale authored an article for Law360 about increased scrutiny in the US biotech industry. The article discusses the impact the Foreign Investment Risk Review and Modernization Act (FIRRMA) has had on the authority of the Committee on Foreign Investment in the United States (CFIUS).

Read the full Law360 article >>